nurs 6521 final exam (latest solutions) : advanced pharmacology-- with latest answers
nurs 6521 advanced pharmacology with the latest solutions and answers. provides detailed questions and answers. Question 72 A nurse is aware that the concept of selective toxicity is foundational to antimicrobial therapy. Which of the following statements most accurately describes selective toxicity? A drug harms microbes without harming human cells. Question 98 A nurse is caring for a patient who is at 28 weeks' gestation and is receiving terbutaline (Brethine) to control preterm labor. Which of the following assessment parameters should the nurse prioritize? Fetal heart rate (FHR) Question 99 An oncology nurse is aware of the risks for injury that exist around the preparation, transportation, and administration of chemotherapeutic agents. In order to reduce these risks of injury, the nurse should take which of the following actions? Prime the IV tubing with an approved IV solution rather than with the drug itself. A nurse is caring for a 46-year-old female patient who is taking paclitaxel for ovarian cancer. Two or three days after the infusion of the drug, the nurse must closely monitor for which of the following? Neurotoxicity 4 A patient is taking etoposide for a testicular tumor refractory to treatment. The nursing assessment reveals that he is also taking warfarin. The nurse must carefully monitor for which of the following? Elevated prothrombin time 5 During ongoing assessment of a patient receiving 5-FU therapy, the nurse finds the patient's platelet count to be 92,000 cells/mm3. The nurse should do which of the following? Consult the prescriber for discontinuation of the drug
Escuela, estudio y materia
- Institución
- NURS 6521
- Grado
- NURS 6521
Información del documento
- Subido en
- 24 de septiembre de 2022
- Número de páginas
- 11
- Escrito en
- 2022/2023
- Tipo
- Examen
- Contiene
- Preguntas y respuestas
Temas
-
nurse
-
educator
-
targeted therapies
-
erectile dysfunction
-
prescribed drugs
-
prescription
-
alprostadil caverject
-
a 39 year old woman is receiving doxorubicin for the treatment of cancer after each treat